LLY Stock Jumps After FDA Approves Eli Lilly’s Tirzepatide Drug For Weight Loss
November 08, 2023 at 21:16 PM EST
Eli Lilly And Co’s stock saw a notable surge, trading at $610.50, up 1.69% (+$10.14) today, following the Food and Drug Administration’s approval of their blockbuster drug tirzepatide for weight loss.
